Pharmaceutical News

RSS

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

20 Mar 2019

Newly discovered parameters offer more control over efficient release of drugs

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients.

20 Mar 2019

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions.

19 Mar 2019

Cholesterol lowering drug can also help treat cancer-associated cachexia

Brazilian researchers have discovered that a drug regularly prescribed to control cholesterol can also be used to treat cachexia, or wasting syndrome, a condition characterized by rapid weight loss and muscle atrophy associated with extreme physical weakness.

19 Mar 2019

New electronic support system for choosing drug treatment based on patient’s genotype

The science of pharmacogenomics (PGx) studies how genetic variability affects an individual’s response to a drug. Most patients metabolize a medication as expected. But some eliminate it from the body before it can do its work, while others process it slowly, causing it to build up in the body and risk an overdose.

19 Mar 2019

Pharmacists can undertake overall clinical responsibility for patients, shows study

The first evaluation of pharmacists based in accident and emergency departments has concluded that with additional clinical skills, they are able to take on overall clinical responsibility for patients.

19 Mar 2019

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Common medications to treat heartburn linked to increased risks for kidney failure

Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.

19 Mar 2019

Study indicates the benefits of stopping aspirin in heart attack patients

Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Two-drug combinations containing calcium channel blocker significantly lowers BP

In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Use of synthetic psychedelic linked to improvements in depression and anxiety

Johns Hopkins researchers have discovered that use of the synthetic psychedelic 5-methocy-N,-N-dimethyltryptamine appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

19 Mar 2019

Cardiovascular benefits of diabetes drug extend across a wide spectrum of patients, shows study

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

18 Mar 2019

Pharmaceutical News

FDA approves first drug for treatment of postpartum depression in adult women

Newly discovered parameters offer more control over efficient release of drugs

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

Cholesterol lowering drug can also help treat cancer-associated cachexia

New electronic support system for choosing drug treatment based on patient’s genotype

Pharmacists can undertake overall clinical responsibility for patients, shows study

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Common medications to treat heartburn linked to increased risks for kidney failure

Study indicates the benefits of stopping aspirin in heart attack patients

Two-drug combinations containing calcium channel blocker significantly lowers BP

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Use of synthetic psychedelic linked to improvements in depression and anxiety

Cardiovascular benefits of diabetes drug extend across a wide spectrum of patients, shows study

Painkillers taken by pregnant mothers unlikely to cause asthma in the child

Gluten, lactose, food dyes in pills could be causing side effects finds study

US opioid prescriptions drop by a half but it’s not all good news

Statins protect against brain hemorrhages

Medication could mitigate side effects of chemotherapy for breast cancer patients

Success for new cholesterol-lowering drug

Prostate cancer treatment breakthrough

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News